Vinge advised Oncopeptides on the deal. The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds...
You must be a Standard 1 Year member to access this content.
Vinge and Weil, Gotshal & Manges advised MGM on the deal. Cederquist advised the Board of Directors of LeoVegas. Gernandt & Danielsson advised LeoVegas’ founders and...
You must be a Standard 1 Year member to access this content.
Vinge, together with Latham & Watkins, advised EQT AB. EQT AB (publ) has completed the issuance of a EUR 750,000,000 sustainability-linked bond maturing in 2028 and...
You must be a Standard 1 Year member to access this content.
Vinge has advised ABG Sundal Collier and Carnegie on the deal. ABG Sundal Collier and Carnegie partecipated in a capital raising in Xshore of approximately SEK 500 million...
You must be a Standard 1 Year member to access this content.
Wigge & Partners represented tbd30 AB in the transaction. Vinge advised Capillary. tbd30 AB has entered into an agreement to acquire all shares in Spolargruppen Sverige...
You must be a Standard 1 Year member to access this content.
Vinge, Kirkland & Ellis, Sidley and AZB & Partners advised EQT on the deal. Paul, Weiss, Rifkind, Wharton & Garrison, working alongside British Virgin Islands and...
You must be a Standard 1 Year member to access this content.
Baker McKenzie acted as legal adviser to the banks. Vinge advised Calliditas Therapeutics. Calliditas Therapeutics AB (publ) executed a primary issuance of shares of approximately SEK 324...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian and the principal shareholder Fidelio. Vimian Group AB announced the listing of and commencement of trading in its ordinary shares on Nasdaq First North...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian and the principal shareholder Fidelio. Vimian Group AB announced the listing of and commencement of trading in its ordinary shares on Nasdaq First North...
You must be a Standard 1 Year member to access this content.
Vinge has advised ABG Sundal Collier and Carnegie on the deal, while Baker McKenzie advised Permascand. Permascand Top Holding AB, an independent technology-driven manufacturer of electrochemical...
You must be a Standard 1 Year member to access this content.
Vinge advised Sleep Cycle AB on the deal. Sleep Cycle AB announced its listing on Nasdaq Stockholm. The offering circular was published on 28 May 2021...
You must be a Standard 1 Year member to access this content.
Vinge advised Acrinova AB on the deal. Acrinova AB announced a rights issue which will provide Acrinova with issue proceeds amounting to a maximum of SEK...
You must be a Standard 1 Year member to access this content.
